Rasmi G. Nair

Southwestern Medical Center

Medicine · Health Sciences

5h-index140citations47works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Screening and Detection(20), Mycobacterium research and diagnosis(16), Global Cancer Incidence and Screening(8), Gastrointestinal disorders and treatments(7), Colorectal and Anal Carcinomas(6)

Publications47 total

Health Beliefs and Adherence to Lung Cancer Screening in a Diverse Safety-Net Population
Journal of the National Comprehensive Cancer Network·2026
Abstract A022: Exploring the association of quantitative fecal immunochemical test (qFIT) with red-flag symptoms of early onset colorectal cancer
Clinical Cancer Research·2025
Abstract B024: Feasibility of survey-based data collection in a diverse colorectal cancer cohort: Early-onset vs. average-onset
Clinical Cancer Research·2025
Tobacco use and perceived risk of lung cancer in a safety-net population
2025Open Access
Abstract 7408: Factors influencing false positive low-dose computed tomography-based lung cancer screening in an urban, safety-net system
Cancer Research·2025· 1 cited
Impact of the Affordable Care Act and Medicaid Expansion Among Patients With HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphomas
JCO Oncology Practice·2024
Sa1153 INCOMPLETE COLONOSCOPY: PREVALENCE AND ASSOCIATED FACTORS IN 4 HEALTHCARE DELIVERY SYSTEMS
Gastroenterology·2024
Clinical, pathological, and adjuvant chemotherapy use differences among microsatellite unstable and microsatellite stable colon cancers
Journal of the National Cancer Center·2024· 4 citedOpen Access
Supplementary Table S4 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Table S2 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Figure S3 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Figure S2 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Figure S2 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Table S3 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Table S1 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Figure S1 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Table S3 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Table S4 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Supplementary Table S2 from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
Data from Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
2024Open Access
page 1 of 3Next →

Frequent Co-authors

Celette Sugg Skinner(28), Ethan A. Halm(24), Caitlin C. Murphy(23), Jacquelyn M. Lykken(19), Cynthia Ortiz(19), Noel Santini(19), Po‐Hong Liu(19), Ellen Hu(18), Eric J. Kim(18), Theodore R. Levin(18), Lei Wang(17), Beverly B. Green(17), Erin E. Hahn(17), Simon J. Craddock Lee(8), David E. Gerber(6), Praveen Ramakrishnan Geethakumari(6), Ann M. Geiger(4), John V. Cox(4), Jasmin A. Tiro(4), Neal Flomenberg(4)